Cancer deaths in people under 80 can be eliminated by 2050, says UCL report Continued access to innovative treatments and improved prevention strategies will allow cancer deaths in people under 80 years of age to be eliminated by 2050.…
Risk modelling study suggests aspirin’s harms outweigh benefits for younger women For most women, the long-term benefits of aspirin do not outweigh the increase in major gastrointestinal bleeding, say researchers.…
Chemoprevention with tamoxifen cuts risk of breast cancer by almost 30% Tamoxifen used in primary prevention cuts the risk of breast cancer by around 30% and this benefit lasts for at least 20 years, a long-term follow-up of the International Breast Cancer Intervention Study shows.…
